The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
Matte A, Federti E, Kung C, Kosinski PA, Narayanaswamy R, Russo R, Federico G, Carlomagno F, Desbats MA, Salviati L, Leboeuf C, Valenti MT, Turrini F, Janin A, Yu S, Beneduce E, Ronseaux S, Iatcenko I, Dang L, Ganz T, Jung CL, Iolascon A, Brugnara C, De Franceschi L.
Matte A, et al. Among authors: iatcenko i.
J Clin Invest. 2021 May 17;131(10):e144206. doi: 10.1172/JCI144206.
J Clin Invest. 2021.
PMID: 33822774
Free PMC article.